News

Nutriband Inc. Issued Full Patent from the Chinese National Intellectual Property Administrant for Its “Abuse and Misuse Deterrent Transdermal System” Application

ORLANDO, FL / ACCESSWIRE / October 31, 2024 / Nutriband (NASDAQ:NTRB)(NASDAQ:NTRBW), has announced that theChinese National Intellectual Property Administrant (CNIPA)…

4 weeks ago

Star City Recovery: Luxury Rehab and Addiction Treatment Facility for Alcohol and Drugs in Tarzana, California

Detox Treatment With Different Options for Addiction No Matter What Substance You Struggle WithLOS ANGELES, CA / ACCESSWIRE / October…

4 weeks ago

CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping Into a Booming $20 Billion Market

Projected to reach the $20 billion global mushroom market by 2030, CBDL's entry offers shareholders a unique opportunity to capitalize…

4 weeks ago

180 Life Sciences Corp. Retains Senior Technology Consultant and Commences Gaming Technology Platform Integration

PALO ALTO, CA / ACCESSWIRE / October 31, 2024 / 180 Life Sciences Corp. ("180" or the "Company") (NASDAQ:ATNF) today…

4 weeks ago

Moderna to Present at Upcoming Conferences in November 2024

CAMBRIDGE, MA / ACCESSWIRE / October 31, 2024 / Moderna, Inc. (NASDAQ:MRNA), today announced its participation in the following upcoming…

4 weeks ago

Silo Pharma Reports Positive Results in Sterilization and Dissolution Testing of SP-26 Ketamine Implant

The implant demonstrates stability and consistent drug release, supporting further analytical testing and development SARASOTA, FL, Oct. 31, 2024 (GLOBE…

4 weeks ago

Lisata Therapeutics to Participate in Upcoming November 2024 Industry and Investor Events

BASKING RIDGE, N.J., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA), a clinical-stage pharmaceutical company developing innovative…

4 weeks ago

Intelligent Bio Solutions Partners with B2i Digital to Amplify Investor Outreach

Digital Marketing Initiatives to Highlight Innovative Non-Invasive Drug Screening Technology and Market Expansion PlansNEW YORK, Oct. 31, 2024 (GLOBE NEWSWIRE)…

4 weeks ago

Cassava Sciences to Report Third Quarter 2024 Results on November 7, 2024

Conference call and webcast to begin at 8:30 AM ETAUSTIN, Texas, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc.…

4 weeks ago

IMUNON to Hold Third Quarter 2024 Financial Results and Business Update Conference Call on Thursday, November 7, 2024

LAWRENCEVILLE, N.J., Oct. 31, 2024 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage drug-development company focused on developing DNA-mediated…

4 weeks ago